Knoll T, Janitzky V, Michel M S, Alken P, Köhrmann K U
Urologische Klinik, Universitätsklinikum Mannheim, Theodor-Kutzer-Ufer 1-3, 68135 Mannheim, Germany.
Aktuelle Urol. 2003 Mar;34(2):97-101. doi: 10.1055/s-2003-38908.
Cystinuria, an autosomal-recessive disorder, is the cause of 1 - 2 % of all kidney stones observed in adults and about 10 % of those observed in infants. Despite increasing understanding of underlying pathomechanisms, patients still form recurrent stones and have to undergo repeated interventions with increasing risk of renal insufficiency. Dietary and medical metaphylaxis may lower the frequency of recurrent stones but are often not practiced. Regular follow-up examinations and optimal therapy significantly enlarge stone-free intervals. This review offers an overview of the underlying pathogenetic mechanisms as well as guidance for diagnosis, monitoring, metaphylaxis and therapy of cystinuria following the recommendations of the Deutsche Gesellschaft für Urologie (DGU) and the European Association of Urology (EAU).
胱氨酸尿症是一种常染色体隐性疾病,在所有成人肾结石病例中占1%-2%,在婴儿肾结石病例中约占10%。尽管对其潜在发病机制的认识不断加深,但患者仍会反复形成结石,不得不接受反复干预,且肾功能不全风险不断增加。饮食和药物预防可降低结石复发频率,但往往未得到实施。定期随访检查和优化治疗可显著延长无结石间期。本综述根据德国泌尿外科学会(DGU)和欧洲泌尿外科学会(EAU)的建议,概述了潜在的致病机制,并为胱氨酸尿症的诊断、监测、预防和治疗提供指导。